Ohio University

Search within:

Event Details

Symposium Headline

The Diabetes Institute at the Ohio University Heritage College of Osteopathic Medicine would like to invite you to our inaugural Diabetes Research Symposium, Patient Care and Diabetes in Appalachian Ohio and Beyond, to be held November 5 and 6, 2021. The Symposium will showcase diabetes research at Ohio University that is enhancing the future of diabetes care, prevention and cure. The Symposium will be held virtually, with connection details forwarded prior to November 5, 2021.   

Registration is now open through October 22, 2021 - REGISTRATION CLOSED

KEYNOTE SPEAKERS

K.M. Venkat Narayan, MD, MSc, MBA

Dr. Narayan is currently the Ruth and O.C. Hubert Chair of Global Health; director, Emory Global Diabetes Research Center; and professor of medicine & epidemiology at Emory University in Atlanta. He formerly served as chief of the diabetes science branch at the U.S. Centers for Disease Control and Prevention. Prior to this, he was an intramural scholar at the National Institutes of Health (U.S.) and on the faculty at the University of Aberdeen (Scotland). Dr. Narayan is noted for substantial, multidisciplinary work in diabetes and noncommunicable diseases public health. He has been involved in several major national and international multi-center epidemiological studies, public health surveillance, translation research and intervention studies.

Kathleen Dungan, MD, MPH

Dr. Dungan is a professor of medicine in the Division of Endocrinology, Diabetes & Metabolism at the Ohio State University, where she serves as associate director of clinical services for the division and director of endocrine clinical trials. Dr. Dungan earned her medical degree from Ohio State University and completed her residency in internal medicine and fellowship in endocrinology at the University of North Carolina. She then completed her master's in public health at Ohio State University. Her research focuses on diabetes clinical trials and ranges from quality improvement, pharmaceutical and device interventions in the inpatient and outpatient settings.

Sonia Najjar, PhD, MS

Dr. Sonia Michael Najjar, Osteopathic Heritage Foundation John J. Kopchick, Ph.D., Endowed Eminent Research Chair at the Ohio University Heritage College of Osteopathic Medicine, earned a PhD degree in physiology from Stanford Medical School, followed by a post-doctoral fellowship at the Diabetes Branch at the National Institutes of Health. She is the founding director of the Center for Diabetes and Endocrine Research at the University of Toledo College of Medicine and Life Sciences. Her research examines the pathogenesis of obesity and diabetes, and the integrated physiology of insulin and lipid metabolism in liver. She is best known for being among the first scientists to show that impaired insulin clearance in the liver could cause insulin resistance, obesity, fatty liver disease, hypertension and atherosclerosis; identifying a key role for hepatic insulin clearance in regulating insulin action; and pioneering the identification of an anti-lipogenic role for insulin in the liver. Her lab currently investigates the molecular basis of hepatic fibrosis independently of insulin resistance. She has been continuously funded by the NIH and other nonprofit organizations. She currently serves as PI on four NIH R01s.

Click for Agenda